Tuesday, January 23, 2018 10:42:04 AM
Not only have they proven their live plant extraction process with tea leaves to be extremely efficient (think cost effective!) but it's been validated at the university and will soon be applied to marijuana.
Then, they also have an efficient delivery mechanism to get the nutrients/drugs into the body, also well-tested.
Basically, they've already conquered the majority of the development hurdles required to get us to become a pharmaceutical grade marijuana company. It's taken years of hard work.
Now we're one simple license away from liftoff, with everything in place. Give this company a little time and they could easily position themselves to sell medical marijuana around the world, helping millions of people with diabetes, epilepsy and more.
The potential here is absolutely huge - revenues could easily end up growing to hundreds of millions per year with any kind of successful pharmaceutical business. That would conquer our outstanding shares and instead of the stock just making a run for copper, the sky would be the limit.
There are no guarantees in any business, but the potential here is phenomenal. I'm playing it for dimes/quarters in the next couple of years. Just keep thinking pharmaceuticals! We might just get extremely lucky.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM